JNJ Johnson & Johnson

  1. Stocks
  2. Healthcare
  3. NYSE: JNJ

Price (delayed)

$160.64

Market cap

$386.7B

P/E Ratio

10.55

Dividend/share

$4.81

EPS

$15.23

Enterprise value

$403.31B

Johnson & Johnson is an American multinational corporation founded in 1886 that develops medical devices, pharmaceutical, and consumer packaged goods. Its common stock is a component of the Dow Jones ...

Highlights
Johnson & Johnson's net income has surged by 191% YoY
JNJ's price to earnings (P/E) is 53% lower than its 5-year quarterly average of 22.4
Johnson & Johnson's debt has increased by 23% from the previous quarter but it has decreased by 9% YoY
JNJ's equity is down by 4.8% year-on-year but it is up by 2.2% since the previous quarter
The quick ratio has decreased by 8% QoQ and by 8% YoY
Sector: Healthcare
Industry: Drug Manufacturers - General
Website: https://www.jnj.com/
Peers: PFE MRK NVS SYK

Key stats

What are the main financial stats of JNJ
Market
Shares outstanding
2.41B
Market cap
$386.7B
Enterprise value
$403.31B
Valuations
Price to earnings (P/E)
10.55
Price to book (P/B)
5.4
Price to sales (P/S)
4.91
EV/EBIT
9.85
EV/EBITDA
8.36
EV/Sales
5.12
Earnings
Revenue
$78.71B
EBIT
$40.96B
EBITDA
$48.23B
Free cash flow
$20.3B
Per share
EPS
$15.23
Free cash flow per share
$8.44
Book value per share
$29.72
Revenue per share
$32.7
TBVPS
$40.35
Balance sheet
Total assets
$181.09B
Total liabilities
$109.55B
Debt
$41.49B
Equity
$71.54B
Working capital
$3.88B
Liquidity
Debt to equity
0.58
Current ratio
1.07
Quick ratio
0.77
Net debt/EBITDA
0.34
Margins
EBITDA margin
61.3%
Gross margin
70.4%
Net margin
48.3%
Operating margin
25.7%
Efficiency
Return on assets
22.1%
Return on equity
54%
Return on invested capital
68.5%
Return on capital employed
32.2%
Return on sales
52%
Dividend
Dividend yield
2.99%
DPS
$4.81
Payout ratio
31.6%

JNJ stock price

How has the Johnson & Johnson stock price performed over time
Intraday
0.63%
1 week
3.85%
1 month
9.41%
1 year
-6.99%
YTD
2.49%
QTD
9.91%

Financial performance

How have Johnson & Johnson's revenue and profit performed over time
Revenue
$78.71B
Gross profit
$55.39B
Operating income
$20.24B
Net income
$38.02B
Gross margin
70.4%
Net margin
48.3%
Johnson & Johnson's net income has surged by 191% YoY
Johnson & Johnson's net margin has soared by 178% YoY but it has decreased by 2.4% from the previous quarter
The gross profit is up by 5% YoY
JNJ's revenue is up by 5% year-on-year

Growth

What is Johnson & Johnson's growth rate over time

Valuation

What is Johnson & Johnson stock price valuation
JNJ P/E details
P/E
10.55
P/B
5.4
P/S
4.91
EV/EBIT
9.85
EV/EBITDA
8.36
EV/Sales
5.12
JNJ's price to earnings (P/E) is 53% lower than its 5-year quarterly average of 22.4
JNJ's price to book (P/B) is 8% less than its 5-year quarterly average of 5.9
JNJ's equity is down by 4.8% year-on-year but it is up by 2.2% since the previous quarter
JNJ's revenue is up by 5% year-on-year
The price to sales (P/S) is 2.3% more than the last 4 quarters average of 4.8

Efficiency

How efficient is Johnson & Johnson business performance
The ROS has soared by 159% YoY
Johnson & Johnson's return on invested capital has increased by 3.6% QoQ

Dividends

What is JNJ's dividend history
Dividend details
DPS
$4.81
Dividend yield
2.99%
Payout ratio
31.6%
Recent dividends

Financial health

How did Johnson & Johnson financials performed over time
JNJ's total assets is 65% greater than its total liabilities
JNJ's current ratio is down by 9% since the previous quarter and by 4.5% year-on-year
The quick ratio has decreased by 8% QoQ and by 8% YoY
Johnson & Johnson's debt is 42% less than its equity
Johnson & Johnson's debt has increased by 23% from the previous quarter but it has decreased by 9% YoY
The company's debt to equity rose by 21% QoQ but it fell by 4.9% YoY

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.